On September 24, the FDA granted priority review to the supplemental biologics license application of fam-trastuzumab deruxtecan-nxki (T-DXd; Enhertu) for the first-line treatment of patients with ...
The US president Donald Trump administration has imposed a staggering annual fee of $100,000 (KSh 12.92m) on H-1B visa applications for skilled workers.